Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb Company
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb Company
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2022 Revenue
$46.1B
Source: Annual report / company filing
Bristol-Myers Squibb Company reported $46.1B in revenue for fiscal year 2022. In 2023, revenue declined to $45.9B.
Net revenues reached $46.1 billion, the high point across these years, though Revlimid had begun ceding sales to generic competition that would weigh on the hematology franchise.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $48.2B | — | +7.1% |
| FY2024 | $45.0B | $2.9B | -2.0% |
| FY2023 | $45.9B | — | -0.4% |
| FY2022 | $46.1B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.